Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-1,004,7162 Sequence dependent aggregation
Herein is reported a method for reducing the aggregation of an immunoglobulin in solution comprising the steps of i) comparing the amino acid sequence of the...
US-1,004,7161 Humanized anti-interleukin 3 receptor alpha chain antibodies
The present disclosure provides antibodies that bind to interleukin-3 receptor alpha chain and uses thereof.
US-1,004,7160 Anti-EGFRvIII antibodies and uses thereof
The present invention provides antibodies that bind to the class III variant of EGFR (EGFRvIII) and methods of using the same. According to certain embodiments,...
US-1,004,7159 Bispecific single chain antibodies with specificity for high molecular weight target antigens
The present invention provides a method for the selection of bispecific single chain antibodies comprising a first binding domain capable of binding to an...
US-1,004,7158 Anti-TIGIT antibodies and methods of use
The invention provides anti-TIGIT (T-cell immunoreceptor with Ig and ITIM domains) antibodies and methods of using the same.
US-1,004,7157 Humanized anti-ACTH antibodies and use thereof
The present invention is directed to antibodies and fragments thereof having binding specificity for ACTH. Embodiments of this invention relate to the binding...
US-1,004,7156 Anti-CXCL1, CXCL7 and CXCL8 antibodies and their applications
The invention provides an isolated antibody or a fragment thereof, which is directed to the human chemokines CXCL1, CXCL7 and CXCL8, said antibody or fragment...
US-1,004,7155 Antibodies targeting bone morphogenetic protein 9 (BMP9) and methods therefor
The present invention relates to isolated antibodies and antigen-binding fragments thereof which bind human BMP9 and compositions and methods of use thereof.
US-1,004,7154 Angiopoietin-2 specific antibodies and uses thereof
An Ang2 specific antibody, a method of inhibiting angiogenesis or a method of treating a disease related to the activation and/or overproduction of Ang2 using...
US-1,004,7153 Human antibodies to Fel d1 and methods of use thereof
The present invention provides antibodies that bind to the cat allergen, Fel d1, compositions comprising the antibodies, nucleic acids encoding the antibodies...
US-1,004,7152 Human antibodies to fel D1 and methods of use thereof
The present invention provides antibodies that bind to the cat allergen, Fel d1, compositions comprising the antibodies, nucleic acids encoding the antibodies...
US-1,004,7151 Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
Uses of the protein cereblon as a predictor of clinical sensitivity to cancer, inflammatory diseases, and patient response to drug treatment.
US-1,004,7150 Anti-neublastin antibodies and uses thereof
Antibodies and antigen binding fragments that bind to neublastin polypeptides are disclosed. Also disclosed are methods of using the antibodies and antigen...
US-1,004,7149 Compositions and methods related to antibodies to Staphylococcal protein A
Embodiments concern methods and compositions for treating or preventing a bacterial infection, particularly infection by a Staphylococcus bacterium. Aspects...
US-1,004,7148 Neutralizing GP41 antibodies and their use
Monoclonal neutralizing antibodies are disclosed that specifically bind to the HIV-1 gp41 membrane-proximal external region (MPER). Also disclosed are...
US-1,004,7147 Neutralizing GP41 antibodies and their use
Monoclonal neutralizing antibodies are disclosed that specifically bind to the HIV-1 gp41 membrane-proximal external region (MPER). Also disclosed are...
US-1,004,7146 Broadly-neutralizing anti-HIV antibodies
The present invention relates to anti-HIV antibodies. Also disclosed are related methods and compositions. HIV causes acquired immunodeficiency syndrome (AIDS),...
US-1,004,7145 Antibodies that potently neutralize RSV and uses thereof
The invention relates to antibodies, and antigen binding fragments thereof, that neutralize infection of both group A and group B RSV. The invention also...
US-1,004,7144 Methods of purifying antibodies
The invention provides methods of purifying antibodies using various antibody-specific purification media to rapidly and efficiently separate mixtures of...
US-1,004,7142 Factor VIII variants having a decreased cellular uptake
The present invention relates to modified coagulation factors. In particular, the present invention relates to modied Factor VIII molecules having decreased...
US-1,004,7141 Method of manufacturing a protein by perfusion in media with a low amino acid concentration
Perfusion media are disclosed providing excellent cell density, titer and product quality for production of a therapeutic protein in a perfusion process.
US-1,004,7140 Methods and compositions for the inhibition of TRPV4
TRPV4 activation increases vascular permeability and can be triggered by both chemical and mechanical cues. This activation of TRPV4 can contribute to a number...
US-1,004,7139 Fc fusion high affinity IgE receptor .alpha.-chain
Provided is an Fc fusion high affinity IgE receptor .alpha.-chain having excellent stability at low pH. An Fc fusion protein comprising: (i) a high affinity...
US-1,004,7138 Fusion protein, cells expressing the fusion protein, and uses thereof
Described herein are novel fusion proteins and nucleic acids encoding these fusion proteins. T cells into which such nucleic acids have been introduced are also...
US-1,004,7136 Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s)
The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins...
US-1,004,7135 Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and...
The present invention is directed to novel non-invasive diagnostic tools/compounds to image cancers, especially, melanoma, including metastatic melanoma in...
US-1,004,7134 Process for expression of recombinant proteins in Pichia pastoris using a fed batch model
The present disclosure relates to a comprehensive model for expression of recombinant peptides by Pichia pastoris. The model uses an easily controllable...
US-1,004,7133 Glycosaminoglycan-antagonising fusion proteins and methods of using same
The present invention relates to novel monomeric fusion proteins derived from human GAG binding proteins such as chemokines with increased glycosaminoglycan...
US-1,004,7132 Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
The present disclosure provides isolated stabilized EPO-derived peptides and their mimics that protect against tissue damage in subjects having diverse forms of...
US-1,004,7131 Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates...
US-1,004,7130 Methods and compositions for red-shifted chromophore substitution for optogenetic applications
The present disclosure provides compositions and methods used for optogenetics, wherein the composition comprises an optogenetic device and a retinoid...
US-1,004,7129 Modified alpha hemolysin polypeptides and methods of use
Provided herein are alpha hemolysin polypeptides comprising modified amino acid sequences that can reduce the rate of translocation of a polymer. Also provided...
US-1,004,7128 Encryption of adeno-associated viruses with enzymatically decoded peptide locks
The present invention is a peptide lock that comprises at least one peptide that is genetically encoded into the Adeno-associated virus (AAV) capsid that block...
US-1,004,7127 De novo structural protein design for manufacturing high strength materials
Provided is a supramolecular polypeptide comprising alternating repeats of crystallite-forming subsequences and amorphous subsequences. The crystallite-forming...
US-1,004,7126 Polymyxin derivatives as antimicrobial compounds
The present invention relates to antimicrobial compounds and their uses, and in particular to peptide antibiotics which may be used in the treatment of...
US-1,004,7125 Peptide having activity to improve skin condition and use thereof
A peptide having activity to improve skin condition is described. The peptide exhibits a very excellent effect in improving skin condition by inhibiting MMP2...
US-1,004,7124 Immunotherapy against several tumors including neuronal and brain tumors
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the...
US-1,004,7123 Immunotherapy against several tumors including neuronal and brain tumors
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the...
US-1,004,7122 Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
The invention provides novel compounds that may serve as anticancer therapeutics. The compounds of the invention bind to polo-like kinases through the polo-box...
US-1,004,7121 Amyloid-beta binding proteins
The present invention relates to amyloid-beta (A.beta.) binding proteins. Antibodies of the invention have high affinity to .LAMBDA..beta.(20-42) globulomer or...
US-1,004,7120 Method for producing a composition for treating a tooth lesion
The invention relates to a method for preparing a composition for treating a tooth lesion, said composition comprising peptides that are capable of undergoing...
US-1,004,7119 Inhibitor of apoptosis protein (IAP) antagonists
Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPB), compositions comprising the compounds, and methods of using...
US-1,004,7118 C17-aryl substituted betulinic acid analogs
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid...
US-1,004,7117 Preparation and uses of obeticholic acid
The present invention relates to obeticholic acid: ##STR00001## or a pharmaceutically acceptable salt, solvate or amino acid conjugate thereof. Obeticholic...
US-1,004,7116 Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in...
The present invention regards nanoparticles comprising a sterol and a component derived from Quillaja saponaria Molina selected from quillaja acid and quillaja...
US-1,004,7115 Cyclic dinucleotides useful for the treatment of inter alia cancer
A compound of formula (I) ##STR00001## or a pharmaceutically acceptable salt and tautomers thereof, compositions, combinations and medicaments containing said...
US-1,004,7114 Nucleotide and oligonucleotide prodrugs
The present invention discloses compounds of formula (I): ##STR00001## which exhibit antiviral properties. The present invention further relates to...
US-1,004,7113 Feruloyl-CoA:monolignol transferase
The invention relates to nucleic acids encoding a feruloyl-CoA:monolignol transferase and the feruloyl-CoA:monolignol transferase enzyme that enables...
US-1,004,7112 Fluorescent labeled inhibitors
Provided herein are a series of fluorescently labeled phosphonate and phosphate compounds such as can be used for affinity probes to detect certain enzymes...
US-1,004,7111 RNA interference agents for GST-PI gene modulation
This invention provides compounds, compositions and methods for modulating the expression of human GST-.pi. using RNA interference. The RNA interference...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.